The size of the Lung Cancer Surgery Market in North America was estimated to be USD 9.09 billion in 2023 and is predicted to reach USD 12.17 billion by 2027, with a CAGR of 6.0%.
The incidence of Lung cancer in North America is significantly growing. According to the statistics published by the American Cancer Society, an estimated 234,030 lung cancer cases were identified, and out of those, 154,050 people were dead in 2018. This rising prevalence of lung cancer is directly influencing the growth of the lung cancer surgery market in North America. The population affected by lung cancer due to air pollution in 2020 is comparatively very high from 2015. So, it is expected the rising air pollution levels is estimated to favor the growth of the lung cancer surgery market in North America.
The expensiveness associated with lung cancer surgeries is a key factor restraining market growth. The shortage of appropriate infrastructure, particularly in developing economies, may hinder the market.
The research report on the North America Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories:
North America accounted for the largest share in the market owing to the rising geriatric population, increasing reimbursements for surgeries, and technological advancement in this field.
The unites States is leading the lung cancer surgery market during the review period. Localized lung cancer has been increasing; the growing demand for lung cancer treatment in this country is likely to boost the market. According to the American Lung Association, approximately 541,000 Americans were living with lung cancer in 2018. Increasing initial detection of lung cancer and high awareness, growing quick-rise rate in lung cancer, and enlarging health insurance are making their way for expanding the growth.
Canada is witnessed to have rapid growth followed after the U.S. and is the second leading country during the analysis period. Growing older people population, brilliant healthcare set up and rising per capita income, and increasing discretionary expenses are likely to have progression in the country of the region. Canada has used the first-ever robotic surgical system in treating the initial stage of lung cancer along with the lobe of the lung, which escalates the market growth during the analysis period.
Key players in the North American Lung Cancer Surgery Market include Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Inc., KARL STORZ GmbH, Scanlan International Inc., and Trokamed GmbH.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]